Product Details
Place of Origin: China
Brand Name: Hongbaiyi
Certification: COA, HPLC MR
Model Number: HBY-Reta
Document: Product Brochure PDF
Payment & Shipping Terms
Minimum Order Quantity: 5 boxes
Price: Negotiable
Packaging Details: 60mg/vial, 10vials/box
Delivery Time: 3-5 work days after your payment
Payment Terms: T/T, MoneyGram, Western Union
Supply Ability: 20,000boxes/Month
Name: |
Reta 12mg For Sale |
CAS: |
2381089-83-2 |
MW: |
4845.444 |
MF: |
C223H343F3N46O70 |
Color: |
White |
Material: |
Powder |
Specification: |
10mg, 15mg, 60mg |
MOQ: |
5 Boxes |
Name: |
Reta 12mg For Sale |
CAS: |
2381089-83-2 |
MW: |
4845.444 |
MF: |
C223H343F3N46O70 |
Color: |
White |
Material: |
Powder |
Specification: |
10mg, 15mg, 60mg |
MOQ: |
5 Boxes |
Research Grade Cas 2381089-83-2 (LY-3437943) RT30 Peptide With Fast Shipping
Reta (LY-3437943) powder is used to treat type 2 diabetes, obstructive sleep apnea, osteoarthritis, obesity, and non-alcoholic fatty liver disease. Reta peptide is a triple hormone receptor agonist for GLP-1, GIP, and GCGR receptors. By activating these receptors, Reta may help regulate appetite, increase energy expenditure, and improve glucose metabolism.
Chemical Property:
| Product Name: | Reta |
| CAS No.: | 2381089-83-2 |
| Molecular Formula: | C223H343F3N46O70 |
| Molecular Weight: | 4845.444 |
| Sequence: |
Tyr- {Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile- {α-Me-Leu}-Leu-Asp-Lys- {diacid |
| Other names/Synonyms: | LY-3437943 |
| Storage Temp: | Please seal and store at 8°C–20°C |
What is the mechanism of action of Reta?
As a triple agonist peptide diet pill to help control obesity, Ridarutide powder targets three different hormones in the body: gastric inhibitory peptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon.
GIP and GLP-1
Blood Sugar Control
After njection, eating food raises blood sugar, triggering GIP and GLP-1, which stimulate insulin secretion and increase blood insulin levels, lowering blood sugar and ultimately promoting weight loss.
Reduces Appetite
GLP-1 and GIP also affect appetite. They delay gastric emptying (GE), reducing hunger and increasing satiety, thus reducing food intake and achieving weight loss.
Glucagon
During prolonged periods of no carbohydrate intake (e.g., during sleep, adherence to a low-calorie diet, or intermittent fasting), glucagon promotes the breakdown of glycogen into glucose for energy, which in turn breaks down fat over a period of time, leading to weight loss.
Reta In Type 2 Diabetes
| Group | Dosage (mg) | Change in HbA1c at 24 weeks (%) | Change in HbA1c at 36 weeks (%) | Weight change (kg) |
| Placebo | 0 | -0.01 (0.21) | -0.13 (0.25) | -0.54 (0.73) |
| Reta | 0.5 | -0.43 (0.20) | -0.64 (0.26) | -1.45 (0.80) |
| Reta | 1.5 | -1.39 (0.14) | -1.64 (0.19) | -2.78 (0.64) |
| Reta | 4 (increasing) | -1.30 (0.22) | -1.51 (0.25) | -2.51 (0.71) |
| Reta | 8 (slowly increasing) | -1.99 (0.15) | -2.28 (0.18) | -3.42 (0.58) |
| Retat | 8 (rapidly increasing) | -1.88 (0.21) | -2.13 (0.24) | -3.17 (0.67) |
| Reta | 12 | -2.02 (0.11) | -2.36 (0.15) | -3.83 (0.51) |
Product Images:
HPLC:
